An injection of MTX and oral roflumilast were given to the MTX + roflumilast group once daily for four consecutive days
DOI: 10.3390/ijms19071987 BPC-157 angiogenic signaling VEGFR2AkteNOS activation, nitric oxide bioavailability, FAK-paxillin cell-anchoring cascade, anti-cytokine modulation: PMC8275860 TB-4 / TB-500 G-actin sequestration and threshold-saturation mechanism actin-monomer binding, cytoskeletal mobilization for cell migration, mass-action pharmacodynamics requiring bolus dosing: PubMed 12581423 TB-4 Ac-SDKP anti-fibrotic fragment N-terminal tetrapeptide (fragment 14) released by meprin- and POP processing
Oxidative stress and disuse muscle atrophy: cause or consequence
Akinola O, Gabriel M, Suleiman A-A, Olorunsogbon F
Wang T, Cornel EJ, Li C, Du J
Zhang Q., Yan L., Lu J., Zhou X